Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Makevale is a global leader in the development and manufacture of high-performance acrylic polymers and resins, primarily serving the healthcare and dental industries. The company specializes in bespoke polymer chemistry, producing materials for critical applications such as orthopedic bone cements, dental prosthetics, and ophthalmic lenses. With manufacturing facilities in the UK, USA, and India, Makevale provides end-to-end services from R&D and pilot-scale synthesis to large-scale GMP production. Their expertise in suspension and emulsion polymerization allows them to create tailored materials with precise physical and chemical properties for medical device and pharmaceutical partners. Makevale is recognized for its rigorous quality standards, including ISO 13485 certification, ensuring the safety and efficacy of its biomaterials in clinical settings. As a key supplier to major medical device companies, they play a vital role in the global supply chain for surgical and restorative materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Makevale.